Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Clinical practice guideline for renal hypouricemia (1st edition).

Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N.

Hum Cell. 2019 Apr;32(2):83-87. doi: 10.1007/s13577-019-00239-3. Epub 2019 Feb 19. Review.

2.

Oligo(ethylene glycol)/alkyl-modified Chromophore Assemblies for Photon Upconversion in Water.

Haruki R, Kouno H, Hosoyamada M, Ogawa T, Yanai N, Kimizuka N.

Chem Asian J. 2019 May 15;14(10):1723-1728. doi: 10.1002/asia.201801666. Epub 2019 Jan 17.

PMID:
30600914
3.

Dynamic Nuclear Polarization of Metal-Organic Frameworks Using Photoexcited Triplet Electrons.

Fujiwara S, Hosoyamada M, Tateishi K, Uesaka T, Ideta K, Kimizuka N, Yanai N.

J Am Chem Soc. 2018 Nov 21;140(46):15606-15610. doi: 10.1021/jacs.8b10121. Epub 2018 Nov 7.

PMID:
30403476
4.

Donor-Acceptor-Collector Ternary Crystalline Films for Efficient Solid-State Photon Upconversion.

Ogawa T, Hosoyamada M, Yurash B, Nguyen TQ, Yanai N, Kimizuka N.

J Am Chem Soc. 2018 Jul 18;140(28):8788-8796. doi: 10.1021/jacs.8b04542. Epub 2018 Jul 9.

PMID:
29940103
5.

Translating MOF chemistry into supramolecular chemistry: soluble coordination nanofibers showing efficient photon upconversion.

Hosoyamada M, Yanai N, Okumura K, Uchihashi T, Kimizuka N.

Chem Commun (Camb). 2018 Jun 19;54(50):6828-6831. doi: 10.1039/c8cc01594e.

PMID:
29637213
6.

Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.

Kawamorita Y, Shiraishi T, Tamura Y, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Nakagawa T, Uchida S.

Physiol Rep. 2017 Aug;5(15). pii: e13358. doi: 10.14814/phy2.13358.

7.

Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2.

Toyoki D, Shibata S, Kuribayashi-Okuma E, Xu N, Ishizawa K, Hosoyamada M, Uchida S.

Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F826-F834. doi: 10.1152/ajprenal.00012.2017. Epub 2017 Jul 5.

8.

Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.

Asakawa S, Shibata S, Morimoto C, Shiraishi T, Nakamura T, Tamura Y, Kumagai T, Hosoyamada M, Uchida S.

Oxid Med Cell Longev. 2017;2017:3759153. doi: 10.1155/2017/3759153. Epub 2017 Feb 28.

9.

Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain.

Tomioka NH, Tamura Y, Takada T, Shibata S, Suzuki H, Uchida S, Hosoyamada M.

Fluids Barriers CNS. 2016 Dec 12;13(1):22.

10.

Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury.

Hosoyamada M, Tsurumi Y, Hirano H, Tomioka NH, Sekine Y, Morisaki T, Uchida S.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):543-549.

PMID:
27906636
11.

Uric acid metabolism of kidney and intestine in a rat model of chronic kidney disease.

Nagura M, Tamura Y, Kumagai T, Hosoyamada M, Uchida S.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):550-558.

PMID:
27906625
12.

Urinary excretion of uric acid, allantoin, and 8-OH-Deoxyguanosine in uricase-knockout mice.

Inazawa K, Yamaguchi S, Hosoyamada M, Fukuuchi T, Tomioka NH, Yamaoka N, Kaneko K.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):559-565.

PMID:
27906613
13.

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ooyama K, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N; Eurogout Consortium, Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, Matsuo H; Eurogout Consortium.

Ann Rheum Dis. 2017 May;76(5):869-877. doi: 10.1136/annrheumdis-2016-209632. Epub 2016 Nov 29.

14.

The Mechanism of False in Vitro Elevation of Uric Acid Level in Mouse Blood.

Watanabe T, Tomioka NH, Watanabe S, Suzuki Y, Tsuchiya M, Hosoyamada M.

Biol Pharm Bull. 2016 Jul 1;39(7):1081-4. doi: 10.1248/bpb.b15-01046. Epub 2016 May 10.

15.

Molecularly Dispersed Donors in Acceptor Molecular Crystals for Photon Upconversion under Low Excitation Intensity.

Hosoyamada M, Yanai N, Ogawa T, Kimizuka N.

Chemistry. 2016 Feb;22(6):2060-2067. doi: 10.1002/chem.201503318. Epub 2016 Jan 8.

PMID:
26748835
16.

Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.

Uchida S, Chang WX, Ota T, Tamura Y, Shiraishi T, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Kaneko K, Shen ZY, Fujimori S.

PLoS One. 2015 Dec 23;10(12):e0145506. doi: 10.1371/journal.pone.0145506. eCollection 2015.

17.

Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat.

Utami SB, Mahati E, Li P, Maharani N, Ikeda N, Bahrudin U, Munemura C, Hosoyamada M, Yamamoto Y, Yoshida A, Nakayama Y, Higaki K, Nanba E, Ninomiya H, Shirayoshi Y, Ichida K, Yamamoto K, Hosoya T, Hisatome I.

Clin Exp Nephrol. 2015 Aug;19(4):576-84. doi: 10.1007/s10157-014-1032-8. Epub 2014 Sep 20.

PMID:
25239792
18.

Identification of a hypouricemia patient with SLC2A9 R380W, a pathogenic mutation for renal hypouricemia type 2.

Chiba T, Matsuo H, Nagamori S, Nakayama A, Kawamura Y, Shimizu S, Sakiyama M, Hosoyamada M, Kawai S, Okada R, Hamajima N, Kanai Y, Shinomiya N.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):261-5. doi: 10.1080/15257770.2013.857781.

PMID:
24940677
19.

False in vitro and in vivo elevations of uric acid levels in mouse blood.

Watanabe T, Tomioka NH, Watanabe S, Tsuchiya M, Hosoyamada M.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):192-8. doi: 10.1080/15257770.2013.865742.

PMID:
24940669
20.

Ependymal cells of the mouse brain express urate transporter 1 (URAT1).

Tomioka NH, Nakamura M, Doshi M, Deguchi Y, Ichida K, Morisaki T, Hosoyamada M.

Fluids Barriers CNS. 2013 Oct 24;10(1):31. doi: 10.1186/2045-8118-10-31.

21.

Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.

Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T, Kawamura Y, Takada Y, Yamamoto K, Inoue H, Oikawa Y, Naito M, Hishida A, Wakai K, Okada C, Shimizu S, Sakiyama M, Chiba T, Ogata H, Niwa K, Hosoyamada M, Mori A, Hamajima N, Suzuki H, Kanai Y, Sakurai Y, Hosoya T, Shimizu T, Shinomiya N.

Sci Rep. 2013;3:2014. doi: 10.1038/srep02014.

22.

Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice.

Watanabe T, Tomioka NH, Doshi M, Watanabe S, Tsuchiya M, Hosoyamada M.

Biol Pharm Bull. 2013;36(5):741-7.

23.

Decreased extra-renal urate excretion is a common cause of hyperuricemia.

Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, Yamanashi Y, Kasuga H, Nakashima H, Nakamura T, Takada Y, Kawamura Y, Inoue H, Okada C, Utsumi Y, Ikebuchi Y, Ito K, Nakamura M, Shinohara Y, Hosoyamada M, Sakurai Y, Shinomiya N, Hosoya T, Suzuki H.

Nat Commun. 2012 Apr 3;3:764. doi: 10.1038/ncomms1756.

24.

The increased protein level of URAT1 was observed in obesity/metabolic syndrome model mice.

Doshi M, Takiue Y, Saito H, Hosoyamada M.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1290-4. doi: 10.1080/15257770.2011.603711.

PMID:
22132989
25.

Detection of mutant uromodulin in transgenic mouse harboring a mutant human UMOD gene.

Yasuda M, Kaneko K, Hachisu H, Yamaoka N, Mawatari K, Nakagomi K, Minoura N, Hosoyamada M.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1284-9. doi: 10.1080/15257770.2011.611485. Erratum in: Nucleosides Nucleotides Nucleic Acids. 2012;31(2):157. Kaneko, Kiyoka [corrected to Kaneko, Kiyoko].

PMID:
22132988
26.

Diagnostic tests for primary renal hypouricemia.

Sebesta I, Stiburkova B, Bartl J, Ichida K, Hosoyamada M, Taylor J, Marinaki A.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1112-6. doi: 10.1080/15257770.2011.611483.

PMID:
22132965
27.

The effect of female hormones upon urate transport systems in the mouse kidney.

Takiue Y, Hosoyamada M, Kimura M, Saito H.

Nucleosides Nucleotides Nucleic Acids. 2011 Feb;30(2):113-9. doi: 10.1080/15257770.2010.551645.

PMID:
21360409
28.

Enhancement of androgen action in the kidneys of transgenic mice harboring the mutant human UMOD gene.

Takiue Y, Hosoyamada M, Kimura M, Saito H.

J Pharmacol Sci. 2011;115(3):383-9. Epub 2011 Feb 24.

29.

[Recent achievements available for the treatment of hyperuricemia and gout. Preface].

Hosoyamada M.

Nihon Yakurigaku Zasshi. 2010 Dec;136(6):315. Japanese. No abstract available.

PMID:
21218662
30.

Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.

Konishi K, Hori K, Uchida H, Watanabe K, Tominaga I, Kimura M, Hosoyamada M, Shibasaki T, Kataoka A, Hachisu M.

Psychogeriatrics. 2010 Mar;10(1):34-8. doi: 10.1111/j.1479-8301.2010.00310.x.

31.

The effect of testosterone upon the urate reabsorptive transport system in mouse kidney.

Hosoyamada M, Takiue Y, Shibasaki T, Saito H.

Nucleosides Nucleotides Nucleic Acids. 2010 Jul;29(7):574-9. doi: 10.1080/15257770.2010.494651.

PMID:
20589576
32.

Development of LC-MS method for detection of mutant uromodulin protein.

Yasuda M, Kaneko K, Hachisu H, Ochiai M, Yamanobe T, Mawatari K, Nakagomi K, Minoura N, Hosoyamada M.

Nucleosides Nucleotides Nucleic Acids. 2010 Jun;29(4-6):515-7. doi: 10.1080/15257771003741356.

PMID:
20544546
33.

Establishment and analysis of SLC22A12 (URAT1) knockout mouse.

Hosoyamada M, Takiue Y, Morisaki H, Cheng J, Ikawa M, Okabe M, Morisaki T, Ichida K, Hosoya T, Shibasaki T.

Nucleosides Nucleotides Nucleic Acids. 2010 Jun;29(4-6):314-20. doi: 10.1080/15257771003738634.

PMID:
20544513
34.

Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA.

Nindita Y, Hamada T, Bahrudin U, Hosoyamada M, Ichida K, Iwai C, Urashima S, Kuwabara M, Utami SB, Mizuta E, Yamada K, Igawa O, Shigemasa C, Ninomiya H, Tsuchihashi T, Hisatome I.

Arzneimittelforschung. 2010;60(4):186-8. doi: 10.1055/s-0031-1296271. Erratum in: Arzneimittelforschung. 2014 Feb;64(2):103. Kuwabara, Narimasa [corrected to Kuwabara, Masanari].

PMID:
20486468
35.

Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome.

Shimizu M, Khoshnoodi J, Akimoto Y, Kawakami H, Hirano H, Higashihara E, Hosoyamada M, Sekine Y, Kurayama R, Kurayama H, Joh K, Hirabayashi J, Kasai K, Tryggvason K, Ito N, Yan K.

Lab Invest. 2009 Feb;89(2):178-95. doi: 10.1038/labinvest.2008.125. Epub 2008 Dec 15.

36.

Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats.

Shinozaki T, Kimura M, Hosoyamada M, Shibasaki T.

Biol Pharm Bull. 2008 Dec;31(12):2250-4.

37.

Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.

Hamada T, Ichida K, Hosoyamada M, Mizuta E, Yanagihara K, Sonoyama K, Sugihara S, Igawa O, Hosoya T, Ohtahara A, Shigamasa C, Yamamoto Y, Ninomiya H, Hisatome I.

Am J Hypertens. 2008 Oct;21(10):1157-62. doi: 10.1038/ajh.2008.245. Epub 2008 Jul 31.

PMID:
18670416
38.

Production and characterization of transgenic mice harboring mutant human UMOD gene.

Takiue Y, Hosoyamada M, Yokoo T, Kimura M, Ochiai M, Kaneko K, Ichida K, Hosoya T, Shibasaki T.

Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):596-600. doi: 10.1080/15257770802136065.

PMID:
18600511
39.

Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese.

Ichida K, Hosoyamada M, Kamatani N, Kamitsuji S, Hisatome I, Shibasaki T, Hosoya T.

Clin Genet. 2008 Sep;74(3):243-51. doi: 10.1111/j.1399-0004.2008.01021.x. Epub 2008 May 15.

PMID:
18492088
40.

Progressive accumulation of intrinsic mouse uromodulin in the kidneys of transgenic mice harboring the mutant human uromodulin gene.

Takiue Y, Hosoyamada M, Yokoo T, Kimura M, Shibasaki T.

Biol Pharm Bull. 2008 Mar;31(3):405-11.

41.

Normal cadmium uptake in microcytic anemia mk/mk mice suggests that DMT1 is not the only cadmium transporter in vivo.

Suzuki T, Momoi K, Hosoyamada M, Kimura M, Shibasaki T.

Toxicol Appl Pharmacol. 2008 Mar 15;227(3):462-7. Epub 2007 Nov 17.

PMID:
18076961
42.

A Turkish case with molybdenum cofactor deficiency.

Ichida K, Aydin HI, Hosoyamada M, Kalkanoglu HS, Dursun A, Ohno I, Coskun T, Tokatli A, Shibasaki T, Hosoya T.

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1087-91.

PMID:
17065069
43.

Adiponectin is regulated differently by chronic exercise than by weight-matched food restriction in hyperphagic and obese OLETF rats.

Kimura M, Shinozaki T, Tateishi N, Yoda E, Yamauchi H, Suzuki M, Hosoyamada M, Shibasaki T.

Life Sci. 2006 Oct 26;79(22):2105-11. Epub 2006 Jul 12.

PMID:
16889803
44.

The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases.

Fujii Y, Khoshnoodi J, Takenaka H, Hosoyamada M, Nakajo A, Bessho F, Kudo A, Takahashi S, Arimura Y, Yamada A, Nagasawa T, Ruotsalainen V, Tryggvason K, Lee AS, Yan K.

Kidney Int. 2006 Apr;69(8):1350-9.

45.

[Hyperuricemic nephropathy: Pathogenesis, pathophysiology, and therapy].

Ichida K, Hosoya T, Hosoyamada M.

Nihon Rinsho. 2006 Feb;64 Suppl 2:438-41. Review. Japanese. No abstract available.

PMID:
16523929
46.

[Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].

Hosoyamada M, Shibasaki T, Ichida K.

Nihon Rinsho. 2006 Feb;64 Suppl 2:176-9. Review. Japanese. No abstract available.

PMID:
16523883
47.

Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter.

Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ.

Am J Nephrol. 2005 Sep-Oct;25(5):425-33. Epub 2005 Aug 19.

PMID:
16113518
48.

A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout.

Taniguchi A, Urano W, Yamanaka M, Yamanaka H, Hosoyamada M, Endou H, Kamatani N.

Arthritis Rheum. 2005 Aug;52(8):2576-7. No abstract available.

49.

Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis.

Hosoyamada M, Yan K, Nishibori Y, Takiue Y, Kudo A, Kawakami H, Shibasaki T, Endou H.

J Pharmacol Sci. 2005 Feb;97(2):234-41. Epub 2005 Jan 30.

50.

Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia.

Wakida N, Tuyen DG, Adachi M, Miyoshi T, Nonoguchi H, Oka T, Ueda O, Tazawa M, Kurihara S, Yoneta Y, Shimada H, Oda T, Kikuchi Y, Matsuo H, Hosoyamada M, Endou H, Otagiri M, Tomita K, Kitamura K.

J Clin Endocrinol Metab. 2005 Apr;90(4):2169-74. Epub 2005 Jan 5.

PMID:
15634722

Supplemental Content

Loading ...
Support Center